Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity.
Ackerman ME; Crispin M; Yu X; Baruah K; Boesch AW; Harvey DJ; Dugast AS; Heizen EL; Ercan A; Choi I; Streeck H; Nigrovic PA; Bailey-Kellogg C; Scanlan C; Alter G; The Journal Of Clinical Investigation, 2013, vol. 123, issue 5, p 2183, ISSN 15588238. ISBN 15588238.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef